https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
Sixty-nine patients (18.4%) had pCR. AND had a lower sensitivity without statistical significance (vs. 62.3% [43/69]; 59.4% [41/69], = 0.50 and a significantly higher specificity (vs. 87.0% [267/307]; 90.2% [277/307], = 0.002) than those of T2WI. Both OR and conditional OR combinations resulted in a large increase in sensitivity (vs. 62.3% [43/69]; 81.2% [56/69], 0.001; and 73.9% [51/69], = 0.008, respectively) and a large decrease in specificity (vs. 87.0% [267/307]; 57.0% [175/307], 0.001; and 69.1% [212/307],